Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors

Details for Australian Patent Application No. 2006322187 (hide)

Owner Novartis AG

Inventors Holzer, Philipp; Imbach, Patricia; Furet, Pascal

Agent Davies Collison Cave

Pub. Number AU-A-2006322187

PCT Pub. Number WO2007/065664

Priority 0600931.0 17.01.06 GB; 0525065.9 08.12.05 GB

Filing date 6 December 2006

Wipo publication date 14 June 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/065664 Priority application(s): WO2007/065664

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322206-Aryl acetic acid and ester derivatives and their uses as antiinflammatory

2006322186-Quinazolinone derivatives as vanilloid antagonists